Articles related to BUSINESS & POLICY

With 40% of us expected to develop cancer in our lifetime and 20% likely to die from it, the need for advanced care is more urgent than ever. This collaboration between Dana-Farber and BIDMC represents a significant step towards meeting this need.

The DEA and HHS have extended telehealth prescribing flexibilities through December 31, 2024. This critical service allows for continued prescribing of controlled medications via virtual practice, addressing a significant need for many patients with mental health conditions and substance use disorders.

The recent data breach at 23andMe, which resulted in the theft of millions of data points from specific users, highlights the urgent need for robust security measures in genetic testing companies.

The proposed antiracism framework in dental education could be a game-changer. By addressing systemic racism and improving representation, we can ensure better patient care for all.

Discover how the Inflation Reduction Act influences pharmaceutical innovation and drug pricing. Learn why delaying drug launches might not be an optimal strategy.

Discover how system failures at Messino Cancer Centers have led to a critical decision impacting patient care. Learn more about this significant development and its implications for healthcare delivery.